Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Mixed Tumor, Mesodermal 1Gallbladder Neoplasms 1Endometrial Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1

Interventions

Gemcitabine 6Cisplatin 6Magnetic Resonance Spectroscopy 5Specimen Handling 4Capecitabine 4Biopsy 3pembrolizumab 2durvalumab 2Trastuzumab 2Platinum 2Oxaliplatin 2Leucovorin 2Fluorouracil 21,2-diaminocyclohexaneplatinum II citrate 2varlilumab 1tucatinib 1toripalimab 1peposertib 1guadecitabine 1dehydroftorafur 1cobimetinib 1binimetinib 1avelumab 1atezolizumab 1Tegafur 1Taxes 1S 1 (combination) 1Radiotherapy, Intensity-Modulated 1Radiation Dose Hypofractionation 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Gallbladder Neoplasms × Lymph Node Excision × Clear all
NCT04559139 2026-05-01

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

Eastern Cooperative Oncology Group

Phase 2/3 Active not recruiting
186 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡